Rumored Buzz on active pharmaceutical ingredient manufacturers
“The current problem has uncovered some structural weaknesses while in the EU’s medicines offer chain as well as a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides reported. She recommended that supply chain challenges be resolved in an EU pharmaceutical approach anticipated to get introduced by the end w